JOHN PATIENCE - 30 Sep 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director, 10%+ Owner
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
30 Sep 2021
Net transactions value
+$166,671
Form type
4
Filing time
10 Dec 2021, 14:57:04 UTC
Previous filing
23 Aug 2021
Next filing
22 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Award $166,671 +21,702 +0.5% $7.68 4,365,585 30 Sep 2021 By John Patience Living Trust dated 7/23/1993 F1
holding AXDX Common Stock 39,411 30 Sep 2021 By IRA
holding AXDX Common Stock 2,140,462 30 Sep 2021 By Patience Enterprises LP F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.